These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36170795)

  • 1. Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms.
    Chovanec J; Tunc I; Hughes J; Halstead J; Mateja A; Liu Y; O'Connell MP; Kim J; Park YH; Wang Q; Le Q; Pirooznia M; Trivedi NN; Bai Y; Yin Y; Hsu AP; McElwee J; Lassiter S; Nelson C; Bandoh J; DiMaggio T; Šelb J; Rijavec M; Carter MC; Komarow HD; Sabato V; Steinberg J; Hafer KM; Feuille E; Hourigan CS; Lack J; Khoury P; Maric I; Zanotti R; Bonadonna P; Schwartz LB; Milner JD; Glover SC; Ebo DG; Korošec P; Caughey GH; Brittain EH; Busby B; Metcalfe DD; Lyons JJ
    Blood Adv; 2023 May; 7(9):1796-1810. PubMed ID: 36170795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Basal Serum Tryptase: Disease Distribution and Variability in a Regional Health System.
    Waters AM; Park HJ; Weskamp AL; Mateja A; Kachur ME; Lyons JJ; Rosen BJ; Boggs NA
    J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2424-2435.e5. PubMed ID: 35032694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis.
    Greiner G; Sprinzl B; Górska A; Ratzinger F; Gurbisz M; Witzeneder N; Schmetterer KG; Gisslinger B; Uyanik G; Hadzijusufovic E; Esterbauer H; Gleixner KV; Krauth MT; Pfeilstöcker M; Keil F; Gisslinger H; Nedoszytko B; Niedoszytko M; Sperr WR; Valent P; Hoermann G
    Blood; 2021 Jan; 137(2):238-247. PubMed ID: 32777817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT.
    Valent P; Hoermann G; Bonadonna P; Hartmann K; Sperr WR; Broesby-Olsen S; Brockow K; Niedoszytko M; Hermine O; Chantran Y; Butterfield JH; Greiner G; Carter MC; Sabato V; Radia DH; Siebenhaar F; Triggiani M; Gülen T; Alvarez-Twose I; Staudinger T; Traby L; Sotlar K; Reiter A; Horny HP; Orfao A; Galli SJ; Schwartz LB; Lyons JJ; Gotlib J; Metcalfe DD; Arock M; Akin C
    J Allergy Clin Immunol Pract; 2023 Oct; 11(10):3010-3020. PubMed ID: 37572755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporating Tryptase Genotyping Into the Workup and Diagnosis of Mast Cell Diseases and Reactions.
    Lyons JJ; Greiner G; Hoermann G; Metcalfe DD
    J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1964-1973. PubMed ID: 35597543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia.
    Luskin KT; White AA; Lyons JJ
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2235-2242. PubMed ID: 33744473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heritable risk for severe anaphylaxis associated with increased α-tryptase-encoding germline copy number at TPSAB1.
    Lyons JJ; Chovanec J; O'Connell MP; Liu Y; Šelb J; Zanotti R; Bai Y; Kim J; Le QT; DiMaggio T; Schwartz LB; Komarow HD; Rijavec M; Carter MC; Milner JD; Bonadonna P; Metcalfe DD; Korošec P
    J Allergy Clin Immunol; 2021 Feb; 147(2):622-632. PubMed ID: 32717252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis.
    Mateja A; Wang Q; Chovanec J; Kim J; Wilson KJ; Schwartz LB; Glover SC; Carter MC; Metcalfe DD; Brittain E; Lyons JJ
    J Allergy Clin Immunol; 2022 Mar; 149(3):1010-1017.e10. PubMed ID: 34425177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone.
    Šelb J; Rijavec M; Eržen R; Zidarn M; Kopač P; Škerget M; Bajrović N; Luzar AD; Park YH; Liu Y; Šerbec VČ; Zver S; Košnik M; Lyons JJ; Korošec P
    J Allergy Clin Immunol; 2021 Aug; 148(2):621-626.e7. PubMed ID: 33753098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosis.
    Sordi B; Vanderwert F; Crupi F; Gesullo F; Zanotti R; Bonadonna P; Crosera L; Elena C; Fiorelli N; Ferrari J; Grifoni F; Sciumè M; Parente R; Triggiani M; Palterer B; Mecheri V; Almerigogna F; Santi R; Di Medio L; Brandi ML; Iorno ML; Ciardetti I; Bencini S; Annunziato F; Mannarelli C; Pieri L; Guglielmelli P; Mannelli F; Vannucchi AM
    J Allergy Clin Immunol; 2023 Feb; 151(2):485-493.e11. PubMed ID: 36309122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond.
    Sprinzl B; Greiner G; Uyanik G; Arock M; Haferlach T; Sperr WR; Valent P; Hoermann G
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of inherited genetic differences in human tryptases: Hereditary alpha-tryptasemia and beyond.
    Glover SC; Carter MC; Korošec P; Bonadonna P; Schwartz LB; Milner JD; Caughey GH; Metcalfe DD; Lyons JJ
    Ann Allergy Asthma Immunol; 2021 Dec; 127(6):638-647. PubMed ID: 34400315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary Alpha Tryptasemia: Validation of a Single-Well Multiplex Digital Droplet PCR Assay in a Cohort of Symptomatic Patients.
    Alheraky A; Wierenga ATJ; Simpelaar A; Hesp LB; Minovic I; Bagheri N; Roozendaal C; Span LFR; Oude Elberink HNG; Kema IP; Mulder AB
    Clin Chem; 2024 Feb; 70(2):425-433. PubMed ID: 38073287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal mast cell disorders and hereditary α-tryptasemia as risk factors for anaphylaxis.
    Kačar M; Rijavec M; Šelb J; Korošec P
    Clin Exp Allergy; 2023 Apr; 53(4):392-404. PubMed ID: 36654513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-Tryptase as a Risk-Modifying Factor for Mast Cell-Mediated Reactions.
    Shin H; Lyons JJ
    Curr Allergy Asthma Rep; 2024 Apr; 24(4):199-209. PubMed ID: 38460022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology.
    Giannetti MP; Akin C; Hufdhi R; Hamilton MJ; Weller E; van Anrooij B; Lyons JJ; Hornick JL; Pinkus G; Castells M; Pozdnyakova O
    J Allergy Clin Immunol; 2021 Apr; 147(4):1497-1501.e1. PubMed ID: 33248113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cell activation in the context of elevated basal serum tryptase: genetics and presentations.
    Khoury P; Lyons JJ
    Curr Allergy Asthma Rep; 2019 Nov; 19(12):55. PubMed ID: 31776770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolving the genetics of human tryptases: implications for health, disease, and clinical use as a biomarker.
    O'Connell MP; Lyons JJ
    Curr Opin Allergy Clin Immunol; 2022 Apr; 22(2):143-152. PubMed ID: 35197435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis.
    Giannetti MP; Weller E; Bormans C; Novak P; Hamilton MJ; Castells M
    Ann Allergy Asthma Immunol; 2021 Jun; 126(6):655-660. PubMed ID: 33465452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential mast cell mediators in systemic mastocytosis and hereditary α-tryptasemia.
    Giannetti MP; Godwin G; Weller E; Butterfield JH; Castells M
    J Allergy Clin Immunol; 2022 Nov; 150(5):1225-1227. PubMed ID: 35550148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.